Presentation is loading. Please wait.

Presentation is loading. Please wait.

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 

Similar presentations


Presentation on theme: "Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) "— Presentation transcript:

1 Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)  Pierluigi Bonomo, Isacco Desideri, Mauro Loi, Monica Mangoni, Mariangela Sottili, Livia Marrazzo, Cinzia Talamonti, Daniela Greto, Stefania Pallotta, Lorenzo Livi  Clinical and Translational Radiation Oncology  Volume 9, Pages (February 2018) DOI: /j.ctro Copyright © 2018 The Authors Terms and Conditions

2 Fig. 1 Study schema. Clinical and Translational Radiation Oncology 2018 9, 42-47DOI: ( /j.ctro ) Copyright © 2018 The Authors Terms and Conditions


Download ppt "Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) "

Similar presentations


Ads by Google